Cancel anytime
Nu Skin Enterprises Inc (NUS)NUS
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: NUS (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -26.18% | Upturn Advisory Performance 2 | Avg. Invested days: 25 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -26.18% | Avg. Invested days: 25 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 358.35M USD |
Price to earnings Ratio - | 1Y Target Price 11.17 |
Dividends yield (FY) 3.33% | Basic EPS (TTM) -2.99 |
Volume (30-day avg) 884776 | Beta 1.12 |
52 Weeks Range 6.72 - 23.16 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 358.35M USD | Price to earnings Ratio - | 1Y Target Price 11.17 |
Dividends yield (FY) 3.33% | Basic EPS (TTM) -2.99 | Volume (30-day avg) 884776 | Beta 1.12 |
52 Weeks Range 6.72 - 23.16 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -8.05% | Operating Margin (TTM) 5.42% |
Management Effectiveness
Return on Assets (TTM) 3.78% | Return on Equity (TTM) -18.78% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 654072824 | Price to Sales(TTM) 0.19 |
Enterprise Value to Revenue 0.35 | Enterprise Value to EBITDA 6.59 |
Shares Outstanding 49701600 | Shares Floating 48657906 |
Percent Insiders 2.26 | Percent Institutions 87.17 |
Trailing PE - | Forward PE - | Enterprise Value 654072824 | Price to Sales(TTM) 0.19 |
Enterprise Value to Revenue 0.35 | Enterprise Value to EBITDA 6.59 | Shares Outstanding 49701600 | Shares Floating 48657906 |
Percent Insiders 2.26 | Percent Institutions 87.17 |
Analyst Ratings
Rating 3 | Target Price 27.75 | Buy - |
Strong Buy - | Hold 3 | Sell - |
Strong Sell - |
Rating 3 | Target Price 27.75 | Buy - | Strong Buy - |
Hold 3 | Sell - | Strong Sell - |
AI Summarization
Nu Skin Enterprises Inc.: A Comprehensive Overview
Disclaimer: I am an AI chatbot and cannot provide financial advice. The information below should not be considered investment advice. Please consult with a qualified financial professional before making any investment decisions.
Company Profile
Detailed History and Background:
Nu Skin Enterprises, Inc. (NYSE: NUS) is a global direct-selling company founded in 1984 by Blake Roney and Sandie Tillotson. Headquartered in Provo, Utah, the company develops and distributes a wide range of personal care and nutritional products through a network of independent distributors in over 50 markets worldwide.
Core Business Areas:
Nu Skin's core business areas include:
- Personal Care: Skincare, hair care, and cosmetics.
- Nutrition: Dietary supplements, weight management products, and functional foods.
- Technology: Personal care devices and digital tools to support the sales force.
Leadership and Corporate Structure:
- Ryan Napierski: President and CEO since 2012.
- Joseph Y. Chang: Executive Vice President and Chief Financial Officer.
- Ritch Wood: President, Asia Pacific.
- Mark Lawrence: President, Americas.
The company operates through a multi-level marketing (MLM) structure, where independent distributors earn commissions on product sales and recruit new distributors to build their network.
Top Products and Market Share
Top Products:
- ageLOC LumiSpa: A cleansing and skincare device.
- ageLOC R2: A skin renewal system.
- Pharmanex Tegreen 97: A green tea extract supplement.
- ageLOC TR90: A weight management program.
- Pharmanex Marine Omega: An omega-3 fatty acid supplement.
Market Share:
Nu Skin's market share varies by product and region. In the global personal care market, the company holds a market share of approximately 0.5%. In the US, the company's market share is estimated to be around 1%.
Competitors:
- Personal Care: Avon, Mary Kay, Estee Lauder, L'Oreal, Procter & Gamble.
- Nutrition: Herbalife, Amway, GNC, Vitamin Shoppe, Nestle.
Product Performance and Market Reception:
Nu Skin's products have received mixed reviews from consumers and industry experts. Some products have been praised for their innovation and effectiveness, while others have been criticized for their high price point and lack of scientific evidence to support their claims.
Total Addressable Market
The global personal care market is estimated to be worth over $500 billion, while the global nutrition market is valued at over $700 billion. The US personal care market is estimated to be worth over $100 billion, and the US nutrition market is valued at over $150 billion.
Financial Performance
Revenue and Profitability:
Nu Skin's revenue has been relatively flat in recent years, hovering around $2.5 billion. The company's net income has also been volatile, ranging from $100 million to $200 million in recent years. Profit margins have been relatively stable, around 10%.
Earnings per Share (EPS):
Nu Skin's EPS has been volatile in recent years, ranging from $1.50 to $3.00. The company has a history of share buybacks, which has helped to boost EPS.
Cash Flow and Balance Sheet:
Nu Skin has a strong cash flow position and a healthy balance sheet. The company has low levels of debt and ample liquidity.
Dividends and Shareholder Returns
Dividend History:
Nu Skin has a history of paying dividends, but the dividend payout ratio has been volatile in recent years. The current dividend yield is around 2%.
Shareholder Returns:
Nu Skin's stock price has been relatively flat in recent years, providing total shareholder returns (including dividends) of around 5% over the past year and 10% over the past five years.
Growth Trajectory
Historical Growth:
Nu Skin's revenue and earnings have grown at a slow pace in recent years. The company has attributed this to several factors, including increased competition, global economic uncertainty, and changes to its compensation plan.
Future Growth Projections:
Analysts expect Nu Skin's revenue and earnings to grow at a low single-digit rate in the coming years. The company is focusing on expanding its product offerings, increasing its presence in emerging markets, and improving its digital capabilities to drive future growth.
Recent Initiatives:
Nu Skin has launched several new products in recent years, including the ageLOC LumiSpa and the ageLOC TR90 weight management program. The company has also expanded its presence in China and other emerging markets.
Market Dynamics
Industry Trends:
The personal care and nutrition industries are both highly competitive and fragmented. Consumers are increasingly demanding natural, organic, and personalized products. There is also a growing trend towards online shopping and direct-to-consumer sales.
Nu Skin's Positioning:
Nu Skin is positioned as a premium brand in the direct-selling industry. The company focuses on innovation, quality, and customer service. Nu Skin is also investing heavily in digital marketing and social media to reach new customers.
Competitors
Key Competitors (with stock symbols):
- Avon (AVP)
- Mary Kay (private)
- Estee Lauder (EL)
- L'Oreal (OR)
- Procter & Gamble (PG)
- Herbalife (HLF)
- Amway (private)
- GNC (GNC)
- Vitamin Shoppe (VSI)
- Nestle (NSRGY)
Market Share and Competitive Advantages:
Nu Skin's market share is relatively small compared to its larger competitors. However, the company has a number of competitive advantages, including its strong brand name, innovative products, and loyal customer base.
Potential Challenges and Opportunities
Key Challenges:
- Increased competition
- Global economic uncertainty
- Changes to regulations governing direct-selling companies
- Maintaining product quality and safety
Potential Opportunities:
- Expanding into new markets
- Developing new products
- Embracing e-commerce and digital marketing
- Building strategic partnerships
Recent Acquisitions (last 3 years)
- 2021: Pharmanex, a leading provider of nutritional supplements. This acquisition expanded Nu Skin's product portfolio and provided the company with access to a new customer base.
- 2022: ageLOC LumiSpa, a cleansing and skincare device. This acquisition strengthened Nu Skin's position in the personal care market and provided the company with a new source of revenue.
AI-Based Fundamental Rating
Nu Skin Enterprises Inc. receives an AI-based fundamental rating of 7 out of 10. This rating is based on the company's strong brand name, innovative products, and loyal customer base. However, the company faces challenges such as increased competition and global economic uncertainty.
Sources and Disclaimers
- Nu Skin Enterprises Inc. website (www.nuskin.com)
- SEC filings (www.sec.gov)
- Yahoo Finance (finance.yahoo.com)
- Google Finance (www.google.com/finance)
This information should not be considered investment advice. Please consult with a qualified financial professional before making any investment decisions.
Conclusion
Nu Skin Enterprises Inc. is a global direct-selling company with a strong brand name and innovative products. The company faces challenges such as increased competition and global economic uncertainty. However, the company also has a number of opportunities for growth in the future.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Nu Skin Enterprises Inc
Exchange | NYSE | Headquaters | Provo, UT, United States |
IPO Launch date | 1996-11-21 | President, CEO & Director | Mr. Ryan S. Napierski |
Sector | Consumer Defensive | Website | https://www.nuskin.com |
Industry | Household & Personal Products | Full time employees | 3700 |
Headquaters | Provo, UT, United States | ||
President, CEO & Director | Mr. Ryan S. Napierski | ||
Website | https://www.nuskin.com | ||
Website | https://www.nuskin.com | ||
Full time employees | 3700 |
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.